Comparing tongue diagnosis in myasthenia gravis patients and healthy individuals
Official title: Application of Artificial Intelligence for Precision Medicine in TCM Tongue Diagnosis and Syndrome Differentiation in Myasthenia Gravis Compared to Healthy Controls
Run by National Taipei University of Nursing and Health Sciences · NCT06754020 · Data updated 2026-11-12
This study is testing if looking at tongue images can help doctors better understand myasthenia gravis by comparing the tongues of patients with the tongues of healthy people.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | National Taipei University of Nursing and Health Sciences Academic / other |
| Locations | 1 site (New Taipei City, Tamsui District) |
| Status | Recruiting |
| Started | January 17, 2023 |
| Main results expected | January 17, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT06754020 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with myasthenia gravis who can communicate in Mandarin or Taiwanese and are cognitively alert.
✕Probably not a fit
Patients with severe organ diseases or those unable to complete the required questionnaires due to hearing loss or aphasia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of Traditional Chinese Medicine (TCM) tongue diagnosis in patients with myasthenia gravis compared to healthy controls. It utilizes scientific methods to analyze tongue images, focusing on characteristics such as tongue body, coating, color, and sublingual veins. The goal is to enhance diagnostic accuracy and provide more reliable information for TCM practitioners, thereby improving the clinical application of tongue diagnosis. Participants will undergo tongue imaging and heart rate variability assessments to gather comprehensive data.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods for myasthenia gravis, enhancing patient care and treatment outcomes.
How similar studies have gone: While the integration of TCM with Western medicine is common, the specific application of scientific methods to TCM tongue diagnosis in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosed with myasthenia gravis by a physician. 2. Able to understand and communicate in Mandarin and Taiwanese. 3. Cognitively alert and without a diagnosis of psychiatric disorders. 4. Willing to undergo tongue imaging and instrument measurements. Exclusion Criteria: 1. Patients with severe organ diseases. 2. Hearing loss patients who are unable to complete the questionnaire. 3. Patients with aphasia who are unable to complete the questionnaire. 4. Have eaten food or drinks that can easily contaminate tongue coating within 2 hours.
Where it's running
-
Yi Ting Yeh
New Taipei City, Tamsui District, Taiwan Recruiting
Study contacts
- Study coordinator: Yi Timg Yeh
- Email: reinating90@gmail.com
- Phone: +866-952-166-103
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MG patient registry to track long-term experiences and treatment patterns
This registry collects information from adults with myasthenia gravis to see how symptoms and quality of life change over time and how treatments relate to those changes.
-
Ublituximab maintenance after efgartigimod response in myasthenia gravis
This study tests whether giving ublituximab as maintenance after a positive response to efgartigimod helps adults with myasthenia gravis.
-
Pregnant Women with Neuroimmune Diseases: A long-term follow-up study
This study follows women with neuroimmune diseases and healthy controls through pregnancy and up to ten years to see how pregnancy affects disease activity and outcomes for both mother and baby.
-
Early ravulizumab for adults with myasthenic crisis in the ICU
This project will test whether giving ravulizumab early to adults with AChR-positive generalized myasthenia gravis who are in the ICU for a myasthenic crisis helps speed recovery.
-
KITE-363 treatment for relapsed or refractory autoimmune neurologic diseases
This study will test whether KITE-363 is safe and can help people with relapsed or treatment-resistant autoimmune neurologic diseases such as MS, CIDP, and myasthenia gravis.
-
ADAPT Forward master protocol testing multiple regimens for generalized myasthenia gravis
This platform tests several drug regimens, including efgartigimod IV and empasiprubart IV, in adults with generalized myasthenia gravis to find safer and more effective treatment combinations.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.